|
Invited Speakers:
|
|
Confirmed speakers include: · Michelle Dipp, MD, PhD, Senior Vice President, Head of CEEDD, GlaxoSmithKline· Joanne Waldstreicher, MD, Chief Medical Officer, Johnson & Johnson, Pharmaceuticals· Dr David Nicholson, Senior Vice President, Worldwide Licensing & Knowledge Management, Merck & Co, Inc· Dr Menelas Pangalos, Executive Vice President & Global Head of Innovative Medicines, AstraZeneca· Sam Azoulay MD, Senior Vice President of Medical & Development, Emerging Markets, Pfizer, Inc· Alan I. Taub, Ph.D., Vice President, Global Research & Development, General Motors Company· Terry Hermiston, PhD, Site Head for the Bayer US Innovation Center & Vice President, Biologics Research US, Bayer Healthcare Pharmaceuticals· Dr Alan B. Ezekowitz, Senior Vice President & Franchise Head, Immunology, Respiratory & Endocrine, Merck Research Laboratories· Dr John G. Houston, Senior Vice President, Applied Biotechnology & Discovery Biology, Bristol-Myers Squibb· Dr Andrew Baum, Managing Director, Equity Research, Morgan Stanley· Dr Naomi Aronson, Executive Director, Technology Evaluation Center (TEC), BlueCross & BlueShield Association· Michelle Browner, PhD, Head of Emerging Science & Technologies, Roche Partnering, Hoffmann-La Roche AG· Dr William W. Chin, Executive Dean for Research, Harvard Medical School· Dr Marc Berger, Vice President, Global Health Outcomes, Eli Lilly and Company· Detlev Biniszkiewicz, PhD, Global Head of Portfolio Management & Analysis, Novartis Institutes for BioMedical Research· Roy Baynes, MD, PhD, Vice President, Global Development & Therapeutic Area Head Hematology/Oncology, Amgen, Inc· Dr Michael M. Morrissey, President of Research & Development, Exelixis, Inc· David Weiner MD., Senior Medical Director, Head of Early Clinical Development Neurology Global Clinical Development Unit, EMD Serono, Inc.· Dr Michael Krams, Vice President - Head of Neurology Franchise, Johnson & Johnson· Sandra Panem, PhD, Partner, Cross Atlantic Partners· David Donabedian, Vice President of Strategic Alliances, US CEEDD, GlaxoSmithKline· Rashmi H. Barbhaiya, PhD, CEO & Managing Director, Advinus Therapeutics Pvt Ltd· Dr Richard Evans, Managing Partner, Sector & Sovereign, LLC · Zafrira Avnur, PhD, Director, Roche Partnering, F. Hoffmann-La Roche Ltd
|
|